Clinical trial
Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic…
NCT00061373 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00061373 |
|---|---|
| Title | Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST) |
| Official title | Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST) |
| Acronym | CATALIST |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ischemic Stroke |
| Intervention type | Drug |
| Interventions | Aspirin, tinzaparin sodium, eptifibatide |
| Enrollment | 18 |
| Start date | May 1, 2003 |
| Primary completion | Dec 1, 2009 |
| Completion | Jul 1, 2011 |
| First posted | May 26, 2003 |
| Last update posted | Feb 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: